Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma

Anticancer Research

Volumn 33, Issue 2, 2013, Pages 705-710

  Shiba, Hiroaki ^a   Furukawa, Kenei ^a   Fujiwara, Yuki ^a   Futagawa, Yasuro ^a   Haruki, Koichiro ^a   Wakiyama, Shigeki ^a   Ishida, Yuichi ^a   Misawa, Takeyuki ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Hepatic resection; Hepatocellular carcinoma

Indexed keywords

C REACTIVE PROTEIN; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; BILE LEAKAGE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURGICAL INFECTION; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84875881989     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sugioka A, Tsuzuki T and Kanai T: Post-resection prognosis of patients with hepatocellular carcinoma. Surgery 113: 612-618, 1993.
2. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K and Kawamura E: Prognostic factors after hepatectomy for hepatocellular carcinomas. Cancer 65: 1104-1110, 1990.
3. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM and Wong J: Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years. Ann Surg 234: 63-70, 2001.
4. Bismuth H, Chiche L and Castaing D: Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections. World J Surg 19: 35-41, 1995.
5. Fong Y, Sun RL, Jarnagin W and Blumgart LH: An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229: 790-800, 1999.
6. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS and Chou FF: Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 124: 1025-1028, 1989.
7. Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, Kawano N and Morioka Y: Postoperative recurrence of hepatocellular carcinoma. Ann Surg 211: 28-33, 1990.
8. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T and Yukaya H: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105: 488-494, 1993.
9. Belghiti J, Panis Y, Farges O, Benhamou JP and Fekete F: Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214: 114-117, 1991.
10. Yanaga K, Okudaira S, Kanematsu T and Marsh JW: Hepatic resection for hepatocellular carcinoma. In: Hepatocellular Cancer: Diagnosis and Treatment. Brian Carr (ed.). Humana Press, Totowa, pp. 185-198, 2005.
11. Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T, Ito R, Gocho T, Furukawa K, Fujiwara Y, Hirohara S, Misawa T and Yanaga K: Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 13: 1636-1642, 2009.
12. McMillian DC: An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67: 257-262, 2008.
13. McMillian DC, Crozier JE, Canna K, Angerson WJ and McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22: 881-886, 2007.
14. Fujiwara Y, Shiba H, Furukawa K, Iida T, Haruki K, Sakamoto T, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, Ohashi T and Yanaga K: Glasgow prognostic score is related to blood transfusion requirements and postoperative complications in hepatic resection for hepatocellular carcinoma. Anticancer Res 30: 5129-5136, 2010.
15. Fujiwara Y, Shiba H, Furukawa K, Iida T, Sakamoto T, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, Ohashi T and Yanaga K: Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 17: 892-897, 2010.
16. Haruki K, Shiba H, Fujiwara Y, Furukawa K, Iida T, Ogawa M, Ishida Y, Misawa T, Ohashi T and Yanaga K: Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection: J Surg Oncol 106: 31-35, 2012.
17. Miyagawa S, Makuuchi M, Kawasaki S and Kakazu T: Criteria for safe hepatic resection. Am J Surg 169: 589-594, 1995.
18. Ueno S, Tanabe G, Nuruki K, Hamanoue M, Komorizono Y, Oketani M, Hokotate H, Inoue H, Baba Y, Imamura Y and Aikou T: Prognostic Performance of the New Classification of Primary Liver Cancer of Japan (4th edition) for patients with hepatocellular carcinoma: A validation analysis. Hepatol Res 24: 395-403, 2002.
19. Hurlimann J, Thorbecke GJ and Hochwald GM: The liver as the site of C-reactive protein formation. J Exp Med 123: 365-378, 1966.
20. Mackiewicz A, Speroff T, Ganapathi MK and Kushner I: Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146: 3032-3037, 1991.
21. Rahman SH, Evans J, Toogood GJ, Lodge PA and Prasad KR: Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 143: 247-253, 2008.
22. Lan AK, Luk HN, Goto S, Chen SM, Eng HL, Chen YS, de Villa VH, Wang CC, Cheng YF, Chen CL, Lee JH and Jawan B: Stress response to hepalectomy in patients with a healthy or diseased liver. World J Surg 27: 761-764, 2003.
23. Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, Bae HI, Yun YK and Hwang YJ: Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol 103: 148-151, 2011.
24. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K and Takenaka K: The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103: 1856-1864, 2005.
25. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M and Sawada T: Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol 103: 801-806, 2011.
26. Kinoshita A, Onoda H, Takano K, Imai N, Saeki C, Fushiya N, Miyakawa Y, Nishino H and Tajiri H: Pretreatment serum Creactive protein level predicts poor prognosis in patients with hepatocellular carcinoma. Med Oncol 29: 2800-2808, 2012.
27. Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M and Sata M: Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int 27: 1091-1097, 2007.
28. Halazun KJ, Hardy MA, Rana AA, Woodland DC, Luyten EJ, Mahadev S, Witkowski P, Siegel AB, Brown RS Jr. and Emond JC: Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 250: 141-151, 2009.
29. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP and Prasad KR: Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32: 1757-1762, 2008.
30. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M and Kitano S: Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 139: 755-764, 2008.
31. Bruckner HW, Lavin PT, Plaxe SG, Storch JA and Livstone EM: Absolute granulocyte, lymphocyte, and monocyte counts: Useful determinants of prognosis for patients with metastasis cancer of the stomach. JAMA 247: 1004-1006, 1982.
32. de Jong KP, Hoedemakers RM, Fidler V, Bijzet J, Limburg PC, Peeters PM, Vries EG and Slooff MJ: Portal and systemic hepatectomy in patients with colorectal liver metastases: A prognostic role for C-reactive protein and hepatocyte growth factor. Scand J Gastroenterol 39: 1141-1148, 2004.
33. Morris-Stiff G, Gomez D and Prasad KR: C-Reactive protein in liver cancer surgery. Eur J Surg Oncol 34: 727-729, 2008.